MedPath

Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions

Not Applicable
Completed
Conditions
Lip Rejuvenation
Interventions
Device: Restylane® Silk
Registration Number
NCT03241862
Lead Sponsor
DeNova Research
Brief Summary

20 subjects with mild to severe oral commissures or none to severe perioral lines will be enrolled and injected with Restylane® Silk. Photographs will be taken prior to and 14 days after Optimal Cosmetic Results has been achieved, as judged by the investigator.

Changes in the projected first impression will be assessed by a total of 200 blinded evaluators rating the photographs of subjects from the baseline and from 14 days post achieving the Optimal Cosmetic Results. Changes in subjects' mood will be self-assessed through Subjective Happiness Scale and Happiness Measures questionnaires. Aesthetic alterations will be assessed by the investigator via the Global Aesthetic Improvement Scale, Oral Commissure Severity Scale, and the Perioral Lines Severity Scale as well as by the self-assessment of subjects using the Global Aesthetic Improvement Scale.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Subject is an adult of at least 21 years of age;
  • Subject has mild to severe oral commissures or none to severe perioral lines, as assessed by the treating investigator;
  • Subject is willing and able to provide written informed consent prior to the performance of any study related procedure;
  • Subject is willing and able to comply with the protocol requirements; and
  • Subject is willing and able to provide written photo consent and adhere to the photography and video procedures such as removal of jewelry and makeup
Exclusion Criteria
  • Subjects who have received lip filler treatments in the past 12 months or neurotoxin injections in the past 6 months;
  • Subjects who plan to undergo neurotoxin treatments, ablative skin treatments, facial cosmetic surgery, or other injectable filler treatments during the course of the study;
  • Subjects with a known allergy or sensitivity to any component of the study ingredients;
  • Subjects with a history of bleeding disorders;
  • Female subjects who are pregnant or nursing as well as those who are of childbearing potential but do not employ adequate birth control methods;
  • Subjects with severe allergies manifested by a history of anaphylaxis or presence of multiple severe allergies;
  • Subjects with previous history of sensitivity to amide type local anesthetics;
  • Current history of chronic drug or alcohol abuse;
  • Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study product;
  • Subjects who, in the investigator's opinion, have a history of poor cooperation, non-compliance with medical treatment, or unreliability; and
  • Enrollment in any active study involving the use of investigational devices or drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Restylane® SilkRestylane® SilkAll subjects enrolled in the study will undergo lip rejuvenation treatment with Restylane® Silk.
Primary Outcome Measures
NameTimeMethod
First Impressions1 month

The projected first impressions are assessed by blinded evaluators using photographs.

The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ).

Each of the below First Impression Questionnaire (FIQ) categories is scored between 1 (disagree)-10 (agree) and a total of 8 categories (see below) are assessed for a total possible score of 80. All scores will be graded out of a total possible score of 80 points Social skills Academic Performance Dating Success Occupational success Attractiveness Financial Success Relationship success Athletic success Total scores closer to 80 indicate a more favorable outcome.

Secondary Outcome Measures
NameTimeMethod
Appearance of the Lip and Perioral AreaVisit 1 at Baseline and Visit 3 (Week 4) or Visit 4 (Week 6)

Changes in the appearance of the lip and the perioral area are assessed by the PI using the Oral Commissure Severity Scale (OCSS) at Visit 1 and Visit 3/4

Oral Commissure Severity Scale (OCSS): graded from None (0), Mild (1), Moderate (2), Severe (3)

None: No wrinkle or fold; slight upturned commissures Mild: Shallow, just perceptible wrinkle or crease; horizontal or slightly downturned corners Moderate: Moderately deep and/or long wrinkle or crease; downturned corners Severe: Very deep and/or long wrinkle or crease; frown at rest

Trial Locations

Locations (1)

DeNova Research

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath